Cangene, created in 1984 (United States), from 22 sister brands and 4958 competing brands. Cangene is owned by Emergent Biosolutions, listed on the stock exchange of New York Cangene is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Emergent Biosolutions
(Cangene)
over 5 years*
USD 0.13